On June 13th at the Cabell County Public Library, Brad Hodges president of the National Federation of the Blind of West Virginia, Huntington Area Chapter, will join Drew Massey, clinical services coordinator for Fruth Pharmacy in demonstrating a new audio prescription label.
The Food and Drug Administration Friday announced that it had approved Rapamune (sirolimus), distributed by Pfizer’s Wyeth Pharmaceuticals, as a treatment for the rare lung disease lymphangioleiomyomatosis (LAM).
Fruth Pharmacy has unveiled new technology to make prescription label reading easier for the visually impaired by partnering with AccessaMed to bring a special prescription label into all 26 Fruth Pharmacy locations.
In a new survey of approximately 2,700 American customers, the Canadian International Pharmacy Association found continued demand for safely ordering prescription medications online from licensed Canadian pharmacies.
The Food and Drug Administration has approved Boehringer Ingelheim, Inc.'s Stiolto Respimat (tiotropium bromide and olodaterol), a once-daily inhaler meant to treat obstructed airflow in patients, the company announced Tuesday.
Mergers and acquisitions among pharmaceutical companies has kicked into high gear this year, mirroring the larger trend sweeping across the entire spectrum of the health care industry since the implementation of the Affordable Care Act two years ago.
Is there a niche OTC opportunity on which food, drug and mass retailer pharmacies are not fully capitalizing? If the answer isn’t yes, then the cat is already out of the bag — according to the American Pet Products Association the market for pet supplies and OTC medicines will grow by 4.7% by the end of the year.
While building a 4,500-store retail pharmacy powerhouse in the United States, Walmart also has kept pace with the specialty pharmacy revolution and is positioning itself to play a stronger role in this most innovative, dynamic and complex area of pharmaceutical R&D and bioengineering.
The complex issue of prescription drug abuse and access are not receiving the comprehensive approach that they deserve and greater collaboration is needed among all stakeholders to help find solutions. That was a key message that National Association of Chain Drug Stores CEO Steve Anderson and U.S. Pain Foundation president Paul Gileno shared in a joint op-ed published Tuesday in The Tampa Tribune.